| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on ,
Accepted on ,
State of the Science Conference. Initiative to Decrease Cardiovascular Risk and Increase Quality of Care for Patients Living With HIV/AIDS Executive Summary
Steven K. Grinspoon MD, Conference Co-Chair,
Key words: AHA Conference Proceedings
AIDS
HIV
cardiovascular diseases
myocardial infarction
antiretroviral therapy, highly active
protease inhibitors
This article has been cited by other articles:
![]() |
C. L. McDonald and J. R. Kaltman Cardiovascular disease in adult and pediatric HIV/AIDS. J. Am. Coll. Cardiol., September 22, 2009; 54(13): 1185 - 1188. [Full Text] [PDF] |
||||
![]() |
J. E Ho and P. Y Hsue Cardiovascular manifestations of HIV infection Heart, July 15, 2009; 95(14): 1193 - 1202. [Full Text] [PDF] |
||||
![]() |
S. W. Worm, S. De Wit, R. Weber, C. A. Sabin, P. Reiss, W. El-Sadr, A. D. Monforte, O. Kirk, E. Fontas, F. Dabis, et al. Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency Virus: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study) Circulation, February 17, 2009; 119(6): 805 - 811. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |